glp-1 liver disease Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective Expanding applications of therapies based

An expanded portfolio of multi-agonists would allow physicians to tailor therapy that targets specific facets of metabolic disease

Expert Rev Mol Med 11:e17 Vargas MR, Pehar M, Cassina P, Beckman JS, Barbeito L (2006) Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75 NTR -dependent motor neuron apoptosis

Potential roles of long non-coding RNAs in the pathogenesis of periodontitis: inflammation response, immune infiltration, collagen fibers synthesis, and bone remodeling

Los agonistas del GLP-1 imitan la accin del GLP-1, una hormona intestinal que estimula la secrecin de insulina dependiente de glucosa, regulando la glucemia